title: Biotechs opt for alternative floatation strategy.
authors.forename: Mark
authors.initials: M
authors.lastname: Ratner
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence* / Q000458:organization & administration*; D006801:Humans; D017150:Public Sector / Q000331:legislation & jurisprudence*; D014481:United States